Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 51 - 75 of 401 in total
Main Class Sub Class LM ID Name ▲ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010010
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:1(9Z))
126457378 984.578658 C48H89O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010013
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:1(9Z))
126457381 1012.609958 C50H93O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010009
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:0)
126457377 986.594308 C48H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010012
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:0)
126457380 1014.625608 C50H95O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010008
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/14:0)
126457376 958.563008 C46H87O18P
Glycerophosphoinositolglycans Monoacylglycerophosphoinositolglycans LMGP15040002
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM1(17:0/0:0)
126457659 748.364643 C32H61O17P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010005
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:2(9Z,12Z))
126457373 968.547358 C47H85O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010004
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:1(9Z))
126457372 970.563008 C47H87O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010007
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:1(9Z))
126457375 998.594308 C49H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010006
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:0)
126457374 1000.609958 C49H93O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010002
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/14:0)
126457370 944.547358 C45H85O18P
Glycerophosphoinositolglycans Monoacylglycerophosphoinositolglycans LMGP15040001
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM1(16:0/0:0)
126457658 734.348993 C31H59O17P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010035
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:2(9Z,12Z))
126457403 1010.594308 C50H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010034
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:1(9Z))
126457402 1012.609958 C50H93O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010037
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/18:1(9Z))
126457405 1040.641258 C52H97O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010033
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:0)
126457401 1014.625608 C50H95O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010036
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/18:0)
126457404 1042.656908 C52H99O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010032
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/14:0)
126457400 986.594308 C48H91O18P
Glycerophosphoinositolglycans Monoacylglycerophosphoinositolglycans LMGP15040006
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM1(19:0/0:0)
126457663 776.395943 C34H65O17P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010017
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:2(9Z,12Z))
126457385 996.578658 C49H89O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010016
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:1(9Z))
126457384 998.594308 C49H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010019
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/18:1(9Z))
126457387 1026.625608 C51H95O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010015
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:0)
126457383 1000.609958 C49H93O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010014
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/14:0)
126457382 972.578658 C47H89O18P
Glycerophosphoinositolglycans Monoacylglycerophosphoinositolglycans LMGP15040003
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM1(18:0/0:0)
126457660 762.380293 C33H63O17P

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024